Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy

NCT01672671 is registered in ClinicalTrials.gov with Russian Academy of Medical Sciences as lead sponsor.

NCT NCT01672671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01672671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy
Lead sponsor
Russian Academy of Medical Sciences
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2011
Completion date
November 30, 2015
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early triple negative breast cancer